Overview

Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone

Status:
Unknown status

Trial end date:
2020-03-30

Target enrollment:

Participant gender:

Summary

A randomized Multicentric open-label controlled trial. The primary objective of the study is to assess the improvement of endothelial function under sulodexide + conventional treatment or conventional treatment alone in patients with Leriche-Fontaine stage II peripheral arterial obstructive disease (systolic ankle brachial index ABI < 0. 9).

Phase:

Phase 3

Details

Lead Sponsor:

Alfa Wassermann Tunisia

Collaborator:

Poseidon CRO

Treatments:

Acetylsalicylic acid lysinate
Angiotensin-Converting Enzyme Inhibitors
Atorvastatin
Captopril
Glucuronyl glucosamine glycan sulfate
Platelet Aggregation Inhibitors